Developments Altamira reports protective effects of Bentrio nasal spray against Influenza A virus Altamira Therapeutics (NASDAQ:CYTO) announced positive outcomes from testing Bentrio for prophylactic or therapeutic use in influenza A virus infection. Bentrio is a drug-free nasal spray being developed by the... August 6, 2021